Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry.

European Journal of Surgical Oncology(2018)

Cited 43|Views32
No score
Abstract
The AGAMENON registry suggests that subjects with limited metastatic disease, selected on a clinical basis, can benefit from early surgeries. Prospective trials are needed to confirm these data.
More
Translated text
Key words
Gastric cancer,HER2,Metastasectomy,Metastases,Surgery,AGAMENON
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined